Pratica Medica & Aspetti Legali
Not a member yet
203 research outputs found
Sort by
Un insolito caso di reazione anafilattica da farmaco: cenni clinici e riflessioni medico-legali
Full text linkWe report a case of a cutaneous ulcer in a 49 years-old patient with diabetes and hypertension. Penicillin in pownder for local use was prescribed. A severe anaphylactic reaction was observed. This case leads to some considerations concerning the off-label prescribing, that is to say the prescription of a registered medicine for a use that is not included in the product information. Thus off-label prescribing in dermatology may sometimes be clinically appropriate, it may be associated with a number of clinical, safety and legal issues. Off-label prescribing is acceptable if there is no suitable alternative and an appropriate process for informed consent is needed. The practice of prescribing off-label drugs is common among dermatologists, many of whom had misperceptions about which are the approved indications of the drug and about the legal ramifications of off-label therapies. The authors suggest that understanding the principles of off-label prescribing in conjunction with the mechanisms of drug action in diseases may help clinicians in increasing the safety of their patients and in avoiding legal litigations
Il contenzioso nella terapia implantare: riflessioni odontoiatriche e medico-legali
Full text linkThe Authors examine a dentistry failure due to technical error during surgical treatment and to unsuitable behaviour. The dentist didn’t perform appropriate instrumental evaluations before the surgery, that would have provided useful information about bone size. The Authors analyse informed consensus in implantology and the need of clinical protocols for an acceptable and common behaviour of dental surgeons
Profilassi eparinica nella tromboembolia polmonare: responsabilità professionale e profili giuridici
Full text linkEarly diagnosis of deep vein thrombosis (DVT) is often difficult: DVT can be asimnthomatic and pulmonary thrombo-embolism (PTE) often occur in a sudden and unexpected way. Pharmacological prophylaxis, aiming at reducing the state of blood hypercoagulability, is the elective therapeutic strategy for vein thomboembolism. Pulmonary embolism is not only one of the most common causes of unexpected death in hospitalized patients, but also one of the top diseases leading to medical malpractice lawsuits. This article describes a case where the lack of adequate pharmacological prophylaxis caused the death of a woman for pulmonary thromboembolism. After some clinical and pharmacological considerations about prophylactic measures for PTE, the Authors explore the question of legal liability of medical practitioners in this situation